Concepedia

Fiona MacLaughlin

FM

Statistics

Publications

6

Citations

892

H-Index

6

Active since

1998

Affiliations

Opexa Therapeutics (United States)(Current)

University of Arkansas Medical Center

Fiona MacLaughlin is an author at Opexa Therapeutics (United States) specializing in gene expression, life sciences, and gene delivery.

Publications per year

1998–2003

6

Publications

6

Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery

Fiona MacLaughlin, Russell J. Mumper, Jijun Wang et al. · Journal of Controlled Release · 1998 · 599 citations

Pharmacy, Pharmaceutical Biotechnology, Pharmaceutics +14

Gene Therapy for the Treatment of Hemophilia B Using PINC-Formulated Plasmid Delivered to Muscle with Electroporation

Jason G. Fewell, Fiona MacLaughlin, Vidya Mehta et al. · Molecular Therapy · 2001 · 99 citations · Full text

Life Sciences, Bioengineering, Biotechnology +17

Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid

S Li, Fiona MacLaughlin, Jason G. Fewell et al. · Gene Therapy · 2001 · 77 citations

Life Sciences, Genetics, Molecular Biology +12

Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation

François Nicol, Min Hui Wong, Fiona MacLaughlin et al. · Gene Therapy · 2002 · 55 citations · Full text

Life Sciences, Bioengineering, Biotechnology +17

Widespread regional myocardial transfection by plasmid encoding Del‐1 following retrograde coronary venous delivery

Dongming Hou, Fiona MacLaughlin, Mary Thiesse et al. · Catheterization and Cardiovascular Interventions · 2003 · 40 citations

Medicine, Bioengineering, Cardiology +9

1–5 of 6